NLI
IONS icon

Nippon Life Insurance’s Ionis Pharmaceuticals IONS Stock Holding History

Nippon Life Insurance’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-6,959
Closed -$301K – 280
2014
Q1 		$301K Buy
+6,959
New +$337K 0.01% 263

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nippon Life Insurance's IONS Position: Q2 2014 in Review

Nippon Life Insurance sold out of Ionis Pharmaceuticals (IONS) in Q2 2014, closing a stake of 6,959 shares — an estimated $301K sold.

Nippon Life Insurance first reported a position in IONS in Q1 2014 and held it in 1 quarter. The position peaked at $301K in Q1 2014. 238 funds tracked by Wall St. Rank hold IONS as of Q2 2014.

  • Nippon Life Insurance reported no remaining Ionis Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • Nippon Life Insurance sold 6,959 Ionis Pharmaceuticals shares in Q2 2014, an estimated $301K.
  • Nippon Life Insurance first reported a position in Ionis Pharmaceuticals in Q1 2014 and held it in 1 quarter.
  • Nippon Life Insurance's Ionis Pharmaceuticals position peaked at $301K in Q1 2014.
  • 238 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2014.

Based on Nippon Life Insurance's 13F filing for Q2 2014, filed 5 Aug 2014.